Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,300 papers from all fields of science
Search
Sign In
Create Free Account
Abnormal involuntary movement
Known as:
Abnormal involuntary movements
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
28 relations
AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA
Bradykinesia
Cerebral Palsy
Congenital Cerebral Palsy
Expand
Narrower (9)
Abnormal head movements
Athetosis
Chorea
Choreoathetosis
Expand
Broader (4)
Brain Diseases
Dyskinetic syndrome
Movement Disorders
nervous system disorder
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Evidence for a role for α6∗ nAChRs in l-dopa-induced dyskinesias using parkinsonian α6∗ nAChR gain-of-function mice
T. Bordia
,
M. McGregor
,
J. McIntosh
,
R. Drenan
,
M. Quik
Neuroscience
2015
Corpus ID: 140204833
2012
2012
Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats
Xin-xin Yang
,
Yinghui Chen
,
+4 authors
Zhenguo Liu
Drug Design, Development and Therapy
2012
Corpus ID: 1115204
Background Levodopa is the gold standard in the treatment of Parkinson’s disease (PD). However, long-term levodopa replacement…
Expand
2011
2011
Positive association between striatal serotonin level and abnormal involuntary movements in chronic l-DOPA-treated hemiparkinsonian rats
S. Gil
,
C. Park
,
J. E. Lee
,
Y. Minn
,
H. Koh
Brain Research Bulletin
2011
Corpus ID: 36170184
2011
2011
Role of dopamine D3 and serotonin 5-HT1A receptors in l-DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
M. Gerlach
,
G. Bartoszyk
,
P. Riederer
,
O. Dean
,
M. van den Buuse
Journal of neural transmission
2011
Corpus ID: 19534377
Sarizotan, a 5-HT1A agonist with additional affinity for D3 and D4 receptors, has been demonstrated to have anti-dyskinetic…
Expand
2010
2010
Pre-treatment with dopamine agonists influence l-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat
E. Lane
,
S. Dunnett
Behavioural Brain Research
2010
Corpus ID: 205881121
2009
2009
Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia
Karen L. Eskow Jaunarajs
,
K. Dupre
,
+4 authors
C. Bishop
NeuroReport
2009
Corpus ID: 146229
Dopamine replacement therapy for the treatment of Parkinson's disease leads to deleterious abnormal involuntary movements (AIMs…
Expand
2008
2008
Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements
W. Schmidt
,
H. Lebsanft
,
+5 authors
D. Scheller
Journal of neural transmission
2008
Corpus ID: 24962727
Sustained drug delivery providing continuous dopaminergic stimulation is thought to prevent or delay the induction of motor…
Expand
Review
2008
Review
2008
Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence.
A. Carta
,
L. Frau
,
S. Pontis
,
A. Pinna
,
M. Morelli
Parkinsonism & Related Disorders
2008
Corpus ID: 22461886
1987
1987
Tardive dyskinesia in neuroleptic medicated mentally handicapped subjects
Preethi Rao
,
V. Cowie
,
B. Mathew
Acta Psychiatrica Scandinavica
1987
Corpus ID: 24676092
ABSTRACT— Sixty‐seven neuroleptic medicated mentally handicapped subjects in a hospital were rated on two occasions for abnormal…
Expand
Highly Cited
1974
Highly Cited
1974
Apomorphine in Huntington's chorea: clinical observations and theoretical considerations.
E. Tolosa
,
S. Sparber
Life Science
1974
Corpus ID: 28480625
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE